Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
Diabetes, Obesity & Metabolism|October 23, 2025
An open-label study on ulotaront's effects on insulin-glucose regulation in schizophrenia patients with metabolic syndrome and prediabetes: Part ISnezana Milanovic, Robert Lew, Kuangnan Xiong, et al.European Journal of Pharmacology|April 19, 2008
Translational aspects of pharmacological research into anxiety disorders: the stress-induced hyperthermia (SIH) paradigmChristiaan H Vinkers, Meg J V van Bogaert, Marianne Klanker, et al.Pharmacology Research & Perspectives|December 16, 2014
Effects of D-amino acid oxidase inhibition on memory performance and long-term potentiation in vivoSeth C Hopkins, Una C Campbell, Michele L R Heffernan, et al.Clinical Pharmacokinetics|October 26, 2023
A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy SubjectsHironobu Tsukada, Yu-Luan Chen, Guangqing Xiao, et al.Diabetes, Obesity & Metabolism|October 23, 2025
A double-blind study on ulotaront's impact on weight-related parameters in schizophrenia patients with metabolic syndrome and prediabetes: Part IISnezana Milanovic, Robert Lew, Kuangnan Xiong, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 19, 2023
TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent mannerSung M Yang, Ayan Ghoshal, Jeffrey M Hubbard, et al.Journal of Clinical Pharmacology|June 6, 2022
ECG Evaluation as Part of the Clinical Pharmacology Strategy in the Development of New Drugs: A Review of Current Practices and Opportunities Based on Five Case StudiesBorje Darpo, Marie Borin, Georg Ferber, et al.Scientific Reports|January 6, 2026
A brief visual evoked potential (VEP) modulation assessment of experience-dependent plasticity recorded via wireless dry-EEG headset in Phase 1 clinical unitsEsther C McWilliams, Snezana M Milanovic, Torbjørn Elvsåshagen, et al.The Journal of Pharmacology and Experimental Therapeutics|March 23, 2013
Pharmacodynamic effects of a D-amino acid oxidase inhibitor indicate a spinal site of action in rat models of neuropathic painSeth C Hopkins, Fei-Yue Zhao, Carrie A Bowen, et al.ACS Medicinal Chemistry Letters|January 20, 2022
Ulotaront: A TAAR1 Agonist for the Treatment of SchizophreniaMichele L R Heffernan, Lee W Herman, Scott Brown, et al.Pageof 6